AcouSort
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Medicon Village Se-223 81, Lund, Skane, ...Phone Number
+46 462221276Website
www.acousort.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AcouSort
AcouSort AB specializes in automating sample handling of cells and extracellular vesicles, primarily targeting applications in cell therapy, biomarker discovery, and diagnostics. Their product offerings include advanced research instruments like AcouTrap and AcouWash, which utilize acoustofluidics for efficient, label-free sample processing. The company also provides sample preparation modules and evaluation kits for integration with third-party systems, enhancing the capabilities of life science and diagnostic equipment. AcouSort aims to deliver high-quality results while ensuring the gentle handling of sensitive biological materials.Explore more
AcouSort Org Chart
JO
Staff Engineer
JB
Controls Engineer
QL
Software Engineer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AcouSort your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if AcouSort has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at AcouSort
Earning: See what the market has to say on AcouSort recently announced quarterly report
Funding: Get notified immidiatlly once AcouSort has new funding data
AcouSort, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when AcouSort launches new products
Check out if AcouSort is spiking on competitors!
Click to see if AcouSort had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
AcouSort is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AcouSort is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AcouSort.
AcouSort Tech Stack
A closer look at the technologies used by AcouSort
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
Event
AcouSort News & Media
AcouSort´s rights issue is registered – conversion of BTU into shares and warrants
AcouSort AB (publ) has completed a rights issue of units, consisting of shares and warrants of series TO 2 (the “Warrants”), which ended on 30 November 2023. The rights issue has today, 12 December 2023, been registered with the Swedish Companies Registration Office and the last day for trading in paid subscribed units (“BTU”) is 15 December 2023. The record date is 19 December 2023, after which the BTUs will be converted into shares andFDA approval paves the way for AcouSort’s first OEM commercialization within critical care diagnostics
AcouSort AB (publ) (“AcouSort”, the “Company”) today announces that the Company and its partner within critical care diagnostics have updated their collaboration agreement. The updated agreement follows the FDA approval in the fall of 2023 for the partnering company’s next generation point-of-care diagnostic system containing AcouSort’s acoustofluidics technology. Minimum revenues from the partnership in 2024 are expected to reach approximately SEK 3.5M. AcouSort and its partner within criticalAcouSort's rights issue fully subscribed
AcouSort AB (publ) ("AcouSort" or the “Company") announces today the final outcome of the rights issue of units with pre-emption rights for the Company’s shareholders, consisting of shares and series TO 2 warrants, which concluded on November 30, 2023 (the “Rights Issue"). The Rights Issue has been subscribed to a total of 100.0 percent, of which approximately 70.8 percent was subscribed with the support of subscription rights and approximately 29.2 percent was subscribed without theAcouSort announces preliminary outcome of rights issue
AcouSort AB (publ) ("AcouSort" or the “Company") today announces the preliminary outcome of the rights issue of units, consisting of shares and warrants of series TO2, which was announced on 7 November 2023 (the “Rights Issue”). The preliminary outcome is that the Rights Issue has been subscribed to a total of approximately 93.4 percent, of which approximately 70.8 percent were subscribed with unit rights, approximately 22.6 percent were subscribed without unit rights. Through the Rights
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding AcouSort
Sign Up For FreeTo access detailed company insights
AcouSort AB specializes in automating sample handling of cells and extracellular vesicles, primarily targeting applications in cell therapy, biomarker discovery, and diagnostics. Their product offerings include advanced research instruments like AcouTrap and AcouWash, which utilize acoustofluidics for efficient, label-free sample processing. The co... Read More
